Literature DB >> 26629276

Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

Lisa A Raedler.   

Abstract

Entities:  

Year:  2015        PMID： 26629276      PMCID： PMC4665052     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  15 in total

Review 1.  Diagnosis and treatment of rosacea: state of the art.

Authors:  Hilary E Baldwin
Journal:  J Drugs Dermatol       Date:  2012-06       Impact factor: 2.114

Review 2.  Clinical practice. Rosacea.

Authors:  Frank C Powell
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

3.  Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey--Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002.

Authors:  M A Gupta; A K Gupta; S J Chen; A M Johnson
Journal:  Br J Dermatol       Date:  2005-12       Impact factor: 9.302

4.  Rosacea: update on management and emerging therapies.

Authors:  Robyn S Fallen; Melinda Gooderham
Journal:  Skin Therapy Lett       Date:  2012-12

Review 5.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Sharon Kramer; Ben Carter; Mark A Graber; Zbys Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

6.  Blushing propensity and psychological distress in people with rosacea.

Authors:  Daphne Su; Peter D Drummond
Journal:  Clin Psychol Psychother       Date:  2011-06-23

7.  Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea.

Authors:  S Georgala; A C Katoulis; G D Kylafis; E Koumantaki-Mathioudaki; C Georgala; K Aroni
Journal:  J Eur Acad Dermatol Venereol       Date:  2001-09       Impact factor: 6.166

8.  Burden of Disease: The Psychosocial Impact of Rosacea on a Patient's Quality of Life.

Authors:  Tu T Huynh
Journal:  Am Health Drug Benefits       Date:  2013-07

9.  Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway.

Authors:  Xinxin Ci; Hongyu Li; Qinlei Yu; Xuemei Zhang; Lu Yu; Na Chen; Yu Song; Xuming Deng
Journal:  Fundam Clin Pharmacol       Date:  2009-05-06       Impact factor: 2.748

Review 10.  The cost-effectiveness of rosacea treatments.

Authors:  Kristen Thomas; Christopher B Yelverton; Brad A Yentzer; Rajesh Balkrishnan; Alan B Fleischer; Steven R Feldman
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359
View more
  2 in total

Review 1.  Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.

Authors:  Martin Steinhoff; Marc Vocanson; Johannes J Voegel; Feriel Hacini-Rachinel; Gregor Schäfer
Journal:  Adv Ther       Date:  2016-07-18       Impact factor: 3.845

2.  New indications for topical ivermectin 1% cream: a case series study.

Authors:  Wioletta Barańska-Rybak; Elżbieta Kowalska-Olędzka
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.